2 employees
BunyaVax exploits proprietary vaccine platform technology to develop safe and efficacious vaccines against infectious diseases and cancer.
2017
$83K
from 1 investors over 1 rounds
BunyaVax raised $83K on June 1, 2018
Investors: Executive Agency for Small and Medium-sized Enterprises (EASME)